U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07427537) titled 'Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients' on Jan. 05.
Brief Summary: This study aims to find out whether certain molecules in the blood, called microRNAs, are linked to how often and how severely people develop nerve damage from chemotherapy. The investigators will look at patients receiving cancer drugs known to affect the nerves, such as paclitaxel (used for lung cancer) and oxaliplatin (used for colorectal cancer).
Study Start Date: Jan. 29
Study Type: INTERVENTIONAL
Condition:
Cancer, Lung
Colon Neoplasm
Neuropathy;Peripheral
Intervention:
DIAGNOS...